{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "22828773",
  "DateCompleted": {
    "Year": "2013",
    "Month": "01",
    "Day": "15"
  },
  "DateRevised": {
    "Year": "2012",
    "Month": "08",
    "Day": "02"
  },
  "Article": {
    "ArticleDate": [],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.2459/JCM.0b013e328356a3b2"
    ],
    "Journal": {
      "ISSN": "1558-2035",
      "JournalIssue": {
        "Volume": "13",
        "Issue": "9",
        "PubDate": {
          "Year": "2012",
          "Month": "Sep"
        }
      },
      "Title": "Journal of cardiovascular medicine (Hagerstown, Md.)",
      "ISOAbbreviation": "J Cardiovasc Med (Hagerstown)"
    },
    "ArticleTitle": "Aerobic exercise prescription in patients with chronic heart failure: a review in the beta-blocker era.",
    "Pagination": {
      "StartPage": "570",
      "EndPage": "574",
      "MedlinePgn": "570-4"
    },
    "Abstract": {
      "AbstractText": [
        "Aerobic exercise training is a well-established nonpharmacological tool in patients with clinically stable chronic heart failure. In recent years, \u03b2-blocker therapy has become a primary pharmacologic intervention in patients with chronic heart failure. Despite the undeniable improvements in patients, the \u03b2-blocker era has aroused uncertainties about aerobic exercise intensity prescription. It is well known that aerobic exercise prescription is performed by a percentage of the patient's heart rate reserve and the use of \u03b2-blockers could interfere in this method. For this reason, the aim of this review is to provide an update about aerobic exercise prescription in patients with chronic heart failure who are using \u03b2-blockers."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Unidade de Cirurgia Card\u00edaca Pedi\u00e1trica - Instituto do Cora\u00e7\u00e3o, Hospital das Cl\u00ednicas da Faculdade de Medicina da USP (InCor HC-FMUSP), S\u00e3o Paulo, Brazil. vitor.carvalho@usp.br"
          }
        ],
        "LastName": "Carvalho",
        "ForeName": "Vitor Oliveira",
        "Initials": "VO"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "J Cardiovasc Med (Hagerstown)",
    "NlmUniqueID": "101259752",
    "ISSNLinking": "1558-2027"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Adrenergic beta-Antagonists"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Prescription Drugs"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Adrenergic beta-Antagonists"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Exercise"
    },
    {
      "QualifierName": [
        "methods"
      ],
      "DescriptorName": "Exercise Therapy"
    },
    {
      "QualifierName": [
        "drug therapy",
        "physiopathology",
        "rehabilitation"
      ],
      "DescriptorName": "Heart Failure"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Prescription Drugs"
    }
  ]
}